
---
title: '药明康德2022H1经营效率持续提升，经调整non-IFRS净利润43.01亿元同比增长75.7%，调高全年业绩指引至68%~72%'
categories: 
 - 新媒体
 - 36kr
 - 资讯
headimg: 'https://picsum.photos/400/300?random=7739'
author: 36kr
comments: false
date: Tue, 26 Jul 2022 12:13:08 GMT
thumbnail: 'https://picsum.photos/400/300?random=7739'
---

<div>   
药明康德2022H1经营效率持续提升，经调整non-IFRS净利润43.01亿元同比增长75.7%，调高全年业绩指引至68%~72%  
</div>
            